Skip to main content
. 2014 Oct 14;20(1):456–465. doi: 10.2119/molmed.2014.00004

Table 1.

Subject characteristics and risk factor prevalence according to the rs2453021 genotype in IMPROVE.

Genotype

CC CT TT P
n 1,517 1,510 391
Subject characteristics
 Male sex (%) 48.4 47.9 48.3 0.888
 Age (years) [mean (95% CI)] 64.4 (64.2–64.7) 64.0 (63.8–64.3) 64.1 (63.6–64.7) 0.091
 BMI (kg/m2) [mean (95% CI)] 27.2 (27.0–27.4) 27.3 (27.1–27.5) 27.1 (26.7–27.5) 0.859
 CRP (mg/L) [median (IQR)] 1.86 (0.74–3.67) 1.86 (0.78–3.53) 1.86 (0.80–3.58) 0.719
Risk factors
 Hypercholesterolemia (%) 68.3 69.7 76.2 0.008
 Hypertriglyceridemia (%) 23.7 28.2 27.6 0.012
 Hypoalphalipoproteinemia (%) 12.5 13.7 14.1 0.308
 Hypertension (%) 70.6 67.3 68.3 0.122
 Diabetes (%) 27.9 26.1 24.2 0.114
 Family history of peripheral vascular disease (%)
  No 79.5 77.4 81.3 0.435
  Yes 11.0 13.2 11.0
  Not known 9.6 9.4 7.7
 Family history of cerebrovascular disease (%)
  No 60.3 61.2 59.8 0.902
  Yes 35.2 35.3 36.1
  Not known 4.6 3.6 4.1
 Family history of coronary heart disease (%)
  No 32.9 35.1 34.3 0.389
  Yes 63.2 61.6 62.4
  Not known 3.8 3.2 3.3
 Current smoker (%) 16 15.2 9.5 0.006
 Smoking pack-year category (%)
  Never smoker 48.4 49.6 50.4 0.234
  1st quartile 12.3 12.3 14.9
  2nd quartile 13.8 11.9 12.1
  3rd quartile 11.9 13.4 10.8
  4th quartile 13.6 12.9 11.8

P values are from linear regression and χ2 tests for linear-by-linear association. Dyslipidemia was defined as hypercholesterolemia (mean calculated LDL cholesterol levels >160 mg/dL or treatment with lipid-lowering drugs), hypertriglyceridemia (triglyceride levels >200 mg/dL or treatment with triglyceride-lowering drugs) and hypoalphalipoproteinemia (HDL cholesterol <40 mg/dL). Hypertension was defined as diastolic blood pressure >90 mmHg and/or systolic blood pressure >140 mmHg or treatment with antihypertensive drugs. Diabetes was defined as fasting glucose level >126 mg/dL (7.0 mmol/L) or treatment with insulin or oral hypoglycemic drugs (20). IQR, interquartile range. Genotype: CC, homozygote major C allele; CT, heterozygote; TT, homozygote minor T allele.